Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
483.96
-10.65 (-2.15%)
Nov 14, 2024, 4:00 PM EST - Market closed
Vertex Pharmaceuticals Analyst Ratings
Total Analysts
29
Consensus Rating
Buy
Price Target
$513.58
Upside
+6.12%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Initiates $575 | Strong Buy | Initiates | $575 | +18.81% | Nov 14, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Sell Maintains $361 → $408 | Strong Sell | Maintains | $361 → $408 | -15.70% | Nov 6, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $480 → $486 | Hold | Maintains | $480 → $486 | +0.42% | Nov 5, 2024 |
| UBS | UBS | Strong Buy Maintains $562 → $586 | Strong Buy | Maintains | $562 → $586 | +21.08% | Nov 5, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $480 | Buy | Reiterates | $480 | -0.82% | Nov 5, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $437 → $451 | Hold | Maintains | $437 → $451 | -6.81% | Nov 5, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $510 → $503 | Buy | Maintains | $510 → $503 | +3.93% | Nov 5, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $473 → $476 | Hold | Maintains | $473 → $476 | -1.64% | Nov 5, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $550 → $540 | Buy | Maintains | $550 → $540 | +11.58% | Oct 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $600 | Strong Buy | Reiterates | $600 | +23.98% | Oct 21, 2024 |
| UBS | UBS | Strong Buy Maintains $477 → $562 | Strong Buy | Maintains | $477 → $562 | +16.13% | Oct 17, 2024 |
| Scotiabank | Scotiabank | Hold Initiates $480 | Hold | Initiates | $480 | -0.82% | Oct 16, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $550 → $541 | Strong Buy | Maintains | $550 → $541 | +11.79% | Oct 14, 2024 |
| Raymond James | Raymond James | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 10, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $425 → $437 | Hold | Maintains | $425 → $437 | -9.70% | Oct 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $480 | Buy | Reiterates | $480 | -0.82% | Oct 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.